Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Mr. Hugh McGuireCEO & Executive Director | -43,96k | 14,68k | Derivative Exercise and Sale | 23,90 - 24,31 | 369,16k | - |
| 2026-05-20 | Mr. Hugh McGuireCEO & Executive Director | 5,85k | 142,14k | Derivative Exercise and Retained Stock | 24,31 | 369,16k | 1,61% |
| 2026-05-20 | Mr. Mark A. GarveyCFO & Executive Director | -49,00k | 19,12k | Derivative Exercise and Sale | 23,90 - 24,31 | 372,84k | - |
| 2026-05-20 | Mr. Mark A. GarveyCFO & Executive Director | 892,00 | 21,68k | Derivative Exercise and Retained Stock | 24,31 | 372,84k | 0,24% |
| 2026-04-08 | Mr. Hugh McGuireCEO & Executive Director | 91,70k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-08 | Mr. Mark A. GarveyCFO & Executive Director | 60,37k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-03-25 | Mr. Mark A. GarveyCFO & Executive Director | -17,62k | 354,70k | Vente | 20,13 | 371,95k | -4,52% |
| 2026-03-25 | Mr. Hugh McGuireCEO & Executive Director | 73,99k | 1,49M | Achat | 20,13 | 363,32k | 25,57% |
| 2026-03-25 | Mr. Hugh McGuireCEO & Executive Director | -33,52k | 674,81k | Vente | 20,13 | 363,32k | -8,45% |
| 2026-03-25 | Mr. Mark A. GarveyCFO & Executive Director | 38,89k | 782,85k | Achat | 20,13 | 371,95k | 11,68% |
| 2026-02-27 | Mr. Mark A. GarveyCFO & Executive Director | 21,39k | 436,07k | Derivative Exercise and Retained Stock | 20,38 | 350,68k | 6,50% |
| 2026-02-27 | Mr. Mark A. GarveyCFO & Executive Director | -21,15k | 749,76 | Derivative Exercise and Sale | 20,38 - 20,42 | 350,68k | - |
| 2025-06-12 | Mr. Mark A. GarveyCFO & Executive Director | 40,69k | 599,96k | Derivative Exercise and Retained Stock | 14,75 | 329,28k | 14,10% |
| 2025-06-12 | Mr. Mark A. GarveyCFO & Executive Director | -36,68k | 1,27k | Derivative Exercise and Sale | 14,71 - 14,75 | 329,28k | - |
| 2025-06-12 | Mr. Brian PhelanCEO of Glanbia Nutritionals | 37,88k | 558,60k | Derivative Exercise and Retained Stock | 14,75 | 316,84k | 13,58% |
| 2025-06-12 | Mr. Brian PhelanCEO of Glanbia Nutritionals | -34,15k | 1,19k | Derivative Exercise and Sale | 14,71 - 14,75 | 316,84k | - |
| 2025-06-12 | Mr. Hugh McGuireCEO & Executive Director | 40,62k | 598,93k | Derivative Exercise and Retained Stock | 14,75 | 322,85k | 14,39% |
| 2025-06-12 | Mr. Hugh McGuireCEO & Executive Director | -36,61k | 1,27k | Derivative Exercise and Sale | 14,71 - 14,75 | 322,85k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
